{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"vitelliform-macular-dystrophy-2","columns":[{"gene":"","key":"population-b9f431bdeda6f65036d7","label":"Macular dystrophy, vitelliform, 2","mondoId":"MONDO:0007931","onsetQualifier":null,"originColumnKey":"MONDO:0007931/OMIM:153700","originalViews":[{"key":"MONDO:0007931/OMIM:153700","label":"Macular dystrophy, vitelliform, 2","scopeLabel":"OMIM:153700","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["047590b92e73b1e111110a32254d7c14419985cdd48dd9b76977b81068145fb2","18947b50b1f34f45a15e066993ff72ff8d43327d4055f0c61f91a574d29f2c5f","1eacf15011e53b4872171867b4025992541362016a2c485244621cd5a0a6b2e1","3fb9b3c7364df65bc0558f99446d09d54c3576bdac5628c72370fc62c0e072bc","6477aa87c4fe3e6833c558c5b36f75543806f8f963a0cbe0702e51aa360497ca","e1d647603ea3426660b9f2b1604207db7109daff7f49554cc88178054a452e8c"],"recordQualifiers":{},"scopeLabel":"OMIM:153700","sourceIds":["OMIM:153700"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-ba34e60018cffae222e0","label":"Best vitelliform macular dystrophy","mondoId":"MONDO:0007931","onsetQualifier":null,"originColumnKey":"MONDO:0007931/ORPHA:1243","originalViews":[{"key":"MONDO:0007931/ORPHA:1243","label":"Best vitelliform macular dystrophy","scopeLabel":"ORPHA:1243","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["01f69641b8c71c80e1fb2c73ca8dab3ae7401cecac136adb1a23122940465879","17089dfa7922d475071660948391fc5144d3fb7f4b33a8d49c698b69eb53b131","284ac47ca87967274360214460637b55c77adeb2e80f3f4293d630892e7b570b","8c86d4376ad2489830c1b4741d8aae437f1a220ad3435a317c3609c7d59e9568","bbc11b07971417a4b0b5f1b9528ef2e5c01e8159ebde3d2c2c80963ad51ee1af","de3490b4598873f462df3bfef9d509ebbe2d12974dd1bd37418f39c94c770fc2"],"recordQualifiers":{},"scopeLabel":"ORPHA:1243","sourceIds":["ORPHA:1243"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-b9f431bdeda6f65036d7","population-ba34e60018cffae222e0"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000512","HP:0001139","HP:0000551","HP:0008028","HP:0007754","HP:0012508","HP:0007663"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":12,"sourceGroups":{"omim":6,"orphanet":6}},"features":[{"hpoId":"HP:0000512","label":"Abnormal electroretinogram","primary":true},{"hpoId":"HP:0001139","label":"Chorioretinal scalloped atrophy","primary":true},{"hpoId":"HP:0000551","label":"Color vision defect","primary":true},{"hpoId":"HP:0008028","label":"Cystoid macular degeneration","primary":true},{"hpoId":"HP:0007754","label":"Macular dystrophy","primary":true},{"hpoId":"HP:0012508","label":"Metamorphopsia","primary":true},{"hpoId":"HP:0007663","label":"Reduced visual acuity","primary":true},{"hpoId":"HP:0031526","label":"Subretinal fluid","primary":false},{"hpoId":"HP:0001123","label":"Visual field defect","primary":false},{"hpoId":"HP:0000505","label":"Visual impairment","primary":false}],"ledeHtml":"Best vitelliform macular dystrophy (BVMD) is a slowly progressive form of macular degeneration. Affected people first have normal vision, followed by decreased central visual acuity and distorted vision (metamorphopsia). Peripheral vision is not affected. BVMD is characterized by impaired central visual function and atrophy of the retinal pigment epithelium. (The retina is the back part of the eye that contains the specialized cells that respond to light, known as photoreceptors.) BVMD is usually inherited in an autosomal dominant manner, but autosomal recessive inheritance has been reported. The condition is typically caused by genetic changes in the BEST1 gene; in a few cases the cause is unknown.","mondoId":"MONDO:0007931","node":{"canonicalSlug":"vitelliform-macular-dystrophy-2","comparisons":[{"documentSha256":"095c001766b864f0fee93b0ec235fc600cf22f9f2305f7b430025250c8e89998","key":"legacy-vitelliform-macular-dystrophy","kind":"legacy","label":"vitelliform macular dystrophy","memberIds":["MONDO:0000390","MONDO:0007931","MONDO:0007933","MONDO:0011979","MONDO:0014508","MONDO:0014509","MONDO:0024561"],"mondoId":"MONDO:0000390","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/vitelliform-macular-dystrophy.095c001766b864f0fee93b0ec235fc600cf22f9f2305f7b430025250c8e89998.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Vitelliform macular dystrophy 2","originalSourceId":"ORPHA:1243","paragraphs":["Best vitelliform macular dystrophy (BVMD) is a slowly progressive form of macular degeneration. Affected people first have normal vision, followed by decreased central visual acuity and distorted vision (metamorphopsia). Peripheral vision is not affected. BVMD is characterized by impaired central visual function and atrophy of the retinal pigment epithelium. (The retina is the back part of the eye that contains the specialized cells that respond to light, known as photoreceptors.) BVMD is usually inherited in an autosomal dominant manner, but autosomal recessive inheritance has been reported. The condition is typically caused by genetic changes in the BEST1 gene; in a few cases the cause is unknown."],"rawAttribution":"MONDO:0007931","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:11Z","upstream":"GARD:0000182","url":"https://rarediseases.info.nih.gov/diseases/182"},"ownColumnKeys":["population-b9f431bdeda6f65036d7","population-ba34e60018cffae222e0"],"publication":"published","relationships":[{"kind":"parent","label":"vitelliform macular dystrophy","mondoId":"MONDO:0000390","slug":"vitelliform-macular-dystrophy"},{"kind":"parent","label":"BEST1-related dominant retinopathy","mondoId":"MONDO:0700238","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"01f69641b8c71c80e1fb2c73ca8dab3ae7401cecac136adb1a23122940465879","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1243","disease_name":"Best vitelliform macular dystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001139","is_excluded":false,"label":"Chorioretinal scalloped atrophy","onset_id":null,"reference":"ORPHA:1243","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"047590b92e73b1e111110a32254d7c14419985cdd48dd9b76977b81068145fb2","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:153700","disease_name":"Macular dystrophy, vitelliform, 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0031526","is_excluded":false,"label":"Subretinal fluid","onset_id":null,"reference":"OMIM:153700","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"17089dfa7922d475071660948391fc5144d3fb7f4b33a8d49c698b69eb53b131","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1243","disease_name":"Best vitelliform macular dystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001123","is_excluded":false,"label":"Visual field defect","onset_id":null,"reference":"ORPHA:1243","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"18947b50b1f34f45a15e066993ff72ff8d43327d4055f0c61f91a574d29f2c5f","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:153700","disease_name":"Macular dystrophy, vitelliform, 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000512","is_excluded":false,"label":"Abnormal electroretinogram","onset_id":null,"reference":"OMIM:153700","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1eacf15011e53b4872171867b4025992541362016a2c485244621cd5a0a6b2e1","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:153700","disease_name":"Macular dystrophy, vitelliform, 2","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0007663","is_excluded":false,"label":"Reduced visual acuity","onset_id":null,"reference":"OMIM:153700","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"284ac47ca87967274360214460637b55c77adeb2e80f3f4293d630892e7b570b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1243","disease_name":"Best vitelliform macular dystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000551","is_excluded":false,"label":"Color vision defect","onset_id":null,"reference":"ORPHA:1243","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3fb9b3c7364df65bc0558f99446d09d54c3576bdac5628c72370fc62c0e072bc","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:153700","disease_name":"Macular dystrophy, vitelliform, 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0008028","is_excluded":false,"label":"Cystoid macular degeneration","onset_id":null,"reference":"OMIM:153700","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"6477aa87c4fe3e6833c558c5b36f75543806f8f963a0cbe0702e51aa360497ca","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:153700","disease_name":"Macular dystrophy, vitelliform, 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007754","is_excluded":false,"label":"Macular dystrophy","onset_id":null,"reference":"OMIM:153700","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"8c86d4376ad2489830c1b4741d8aae437f1a220ad3435a317c3609c7d59e9568","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1243","disease_name":"Best vitelliform macular dystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008028","is_excluded":false,"label":"Cystoid macular degeneration","onset_id":null,"reference":"ORPHA:1243","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bbc11b07971417a4b0b5f1b9528ef2e5c01e8159ebde3d2c2c80963ad51ee1af","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1243","disease_name":"Best vitelliform macular dystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"ORPHA:1243","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"de3490b4598873f462df3bfef9d509ebbe2d12974dd1bd37418f39c94c770fc2","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1243","disease_name":"Best vitelliform macular dystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012508","is_excluded":false,"label":"Metamorphopsia","onset_id":null,"reference":"ORPHA:1243","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e1d647603ea3426660b9f2b1604207db7109daff7f49554cc88178054a452e8c","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:153700","disease_name":"Macular dystrophy, vitelliform, 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"OMIM:153700","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/182\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007931\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0000182</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Best vitelliform macular dystrophy (BVMD) is a slowly progressive form of macular degeneration. Affected people first have normal vision, followed by decreased central visual acuity and distorted vision (metamorphopsia). Peripheral vision is not affected. BVMD is characterized by impaired central visual function and atrophy of the retinal pigment epithelium. (The retina is the back part of the eye that contains the specialized cells that respond to light, known as photoreceptors.) BVMD is usually inherited in an autosomal dominant manner, but autosomal recessive inheritance has been reported. The condition is typically caused by genetic changes in the BEST1 gene; in a few cases the cause is unknown.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/182\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"vitelliform-macular-dystrophy-2","sourceDocuments":[{"name":"GARD: Vitelliform macular dystrophy 2","reviewed":null,"source_release":"2026-10-25T03:38:11Z","url":"https://rarediseases.info.nih.gov/diseases/182"},{"name":"MONDO: vitelliform macular dystrophy 2","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0007931"}],"sourceNote":"","synonyms":["Best disease","Best macular dystrophy","Best Vitelliform Macular Dystrophy","BEST1 retinopathy","BMD","BVMD","early-onset vitelliform macular dystrophy","juvenile-onset vitelliform macular dystrophy","macular degeneration, polymorphic vitelline","macular dystrophy, vitelliform, 2","macular dystrophy, vitelliform, type 2","polymorphic vitelline macular degeneration","vitelliform macular dystrophy type 2","vitelliform macular dystrophy, early-onset","vitelliform macular dystrophy, juvenile-onset","vitelliform macular dystrophy, type 2","VMD2"],"takeawayHtml":"","title":"vitelliform macular dystrophy 2"},"schemaVersion":1}
